XML 29 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cost of goods sold $ (719) $ (1,009)
Gross profit 861 2,398
Operating expenses:    
Research and development expenses 9,490 19,650
Selling, general and administrative expenses 11,279 9,819
Total operating expenses 20,769 29,469
Operating loss (19,908) (27,071)
Change in fair value of the warrant liability, net 17,493 19,706
Loss on debt extinguishment   (1,123)
Loss on issuance of financial instrument (1,720) (2,826)
Interest expense (4,746) (7,959)
Other income 2 51
Net loss (8,879) (19,222)
Other comprehensive loss:    
Foreign currency translation adjustments (22) 8
Comprehensive loss $ (8,901) $ (19,214)
Common share data:    
Basic and diluted loss per share [1] $ (1,047) $ (504)
Weighted average number of basic and diluted shares outstanding [1] 25,900 38,151
Product Revenue [Member]    
Revenue $ 1,101 $ 3,378
Other Revenue [Member]    
Revenue $ 479 $ 29
[1] reflects, a one-for-five hundred (1:500) reverse stock split effected on May 2, 2018, and a one-for-seven hundred (1:700) reverse stock split effected on December 24, 2019.